R&D Solutions


Contact Sales

Insights to Improve Drug Development from Target Identification to Post-Launch

Pharma & life sciences organizations depend on data to achieve better R&D outcomes, but finding, interpreting and integrating diverse datasets to quickly discover actionable insights is a universal challenge.

Elsevier R&D Solutions offers tools that solve these data challenges, enabling research teams to predict outcomes based on past experience — an essential task in lead identification, drug development, pharmacovigilance and more — which helps them make better informed research and business decisions.

Supporting All Stages of Drug Discovery & Development

Disease Biology

Elsevier helps organizations understand the biological mechanisms and biomarkers of diseases or abnormal states, enabling the development of new drugs and therapies. 

Learn more

Lead Optimization

Elsevier provides high-quality external data and supports harmonization with internal data to improve hit identification and lead optimization processes.

Learn more

Drug Candidate Selection

Elsevier enables unique access to FDA and EMA drug approval documents and data, and biomedical literature, to enable critical decisions in drug candidate selection, study design and risk mitigation.

Learn more


Elsevier provides optimal literature monitoring and triage strategies to ensure that drug and medical device companies monitor all mentions of adverse events efficiently, and stay compliant on regulatory reporting.

Learn more


Frontiers in Medicinal Chemistry

Antwerp, Belgium, 14 - 16 Sep 2015

Meet the team at our Elsevier R&D Solutions booth (# 14) at FMC 2015 and receive a one on one demo on Reaxys and Reaxys Medicinal Chemistry.

Click here to learn more about
Frontiers in Medicinal Chemistry